We use cookies and similar technologies for analytics, to understand how the site is used. You can accept or decline non-essential cookies. See our Privacy Policy.
Medtronic plc develops, manufactures, and sells device-based medical therapies to healthcare systems, physicians, clinicians, and patients in the United States, Ireland, and internationally. The Cardiovascular Portfolio segment offers implantable cardiac pacemakers, cardioverter defibrillators, and cardiac resynchronization therapy devices; cardiac ablation products; insertable cardiac monitor systems; TYRX products; and remote monitoring and patient-centered software. It also provides aortic valves, surgical valve replacement and repair products, endovascular stent grafts and accessories, and transcatheter pulmonary valves, and percutaneous coronary intervention products, percutaneous angioplasty balloons, and other products. The Neuroscience Portfolio segment offers medical devices and implants, biologic solutions, spinal cord stimulation and brain modulation systems, implantable drug infusion systems, and interventional products, as well as nerve ablation system under the Accurian name. The segment offers its products for spinal surgeons, neurosurgeons, neurologists, pain management specialists, anesthesiologists, orthopedic surgeons, urologists, urogynecologists, and interventional radiologists, as well as ear, nose, and throat specialists, and energy surgical instruments. The Medical Surgical Portfolio segment offers surgical stapling devices, vessel sealing instruments, wound closure and electrosurgery products, AI-powered surgical video and analytics platform, robotic-assisted surgery products, hernia mechanical devices, mesh implants, gynecology products, gastrointestinal and hepatologic diagnostics and therapies, and therapies to treat diseases and conditions, and patient monitoring and airway management products. The Diabetes Operating Unit segment provides insulin pumps and consumables, continuous glucose monitoring systems and sensors, and InPen, a smart insulin pen. Medtronic plc was founded in 1949 and is headquartered in Galway, Ireland.
Medtronic plc는 미국, 아일랜드 및 전 세계적으로 의료 시스템, 의사, 임상의 및 환자에게 기기 기반 의료 치료법을 개발, 제조 및 판매합니다. 심혈관 포트폴리오 부문은 이식형 심장 박동기, 심장 제세동기, 심장 재동기화 치료 기기, 심장 절제술 제품, 삽입형 심장 모니터 시스템, TYRX 제품, 그리고 원격 모니터링 및 환자 중심 소프트웨어를 제공합니다. 또한 대동맥판막, 수술용 판막 교체 및 수리 제품, 혈관 내 스텐트 그라프트 및 액세서리, 경피적 폐동맥판막, 경피적 관상동맥 중재술 제품, 경피적 혈관 성형술 풍선 및 기타 제품을 제공합니다. 신경과학 포트폴리오 부문은 의료 기기 및 임플란트, 생물학적 솔루션, 척수 자극 및 뇌 조절